Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Choice Hotels (CHH)

Choice Hotels adds Ali Keshavarz, CVS Health data and AI executive, to board

Neutral Impact 2 of 5 leadership Written later

Choice Hotels International appointed Ali Keshavarz as a director effective June 26, 2026, expanding the board to twelve members. Keshavarz is President and Chief Data & Analytics Officer of CVS Health, and the company says his AI and analytics expertise will support its long-term growth strategy.

Key points

  • Ali Keshavarz appointed director effective June 26, 2026, with a term expiring at the 2027 Annual Meeting of Shareholders
  • Board size now twelve directors; committee assignments have not been determined
  • Keshavarz previously served as Chief Analytics Officer for Aetna and CVS Caremark and spent more than a decade at McKinsey
  • Director compensation is consistent with other non-employee directors, per the April 22, 2026 proxy statement

The filing

CompanyChoice Hotels (CHH)
Form8-K, current report
Filed with the SECJul 1, 2026, 10:37 AM ET
Accession number0001628280-26-046377

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 01, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.